摘要
目的探讨单孔腹腔镜手术治疗卵巢良性肿物的可行性和相关手术结局。方法选取北京大学第一医院2013年9月至2014年6月收治的80例经腹腔镜手术治疗的卵巢良性肿物患者。其中25例接受经脐单切口腹腔镜手术(single-incision laparoscopic surgery,SILS),25例接受单孔腹腔镜手术(single-port laparoscopic surgery,SPLS),30例接受传统多切口腹腔镜手术(multi-port laparoscopic surgery,MPLS)。回顾性分析三组患者的临床病理特征、手术类型、手术时间、术中出血量、术后住院日等围术期结局。结果 SILS、SPLS、MPLS三组患者手术均成功完成。三组患者临床病理特征差异无统计学意义(P>0.05)。SILS、SPLS和MPLS三组患者手术时间平均51min、56min和45min(P>0.05);术中出血量分别为10ml、10ml和15ml(P>0.05);手术前后血红蛋白变化分别为7g/L、8g/L和6g/L(P>0.05)。结论对于适宜患者,单孔腹腔镜治疗卵巢良性肿物是安全可行的手术方法。
Objective To study the feasibility of transumbilical single-incision laparoscopic surgery (SILS) and single-port laparoseopic surgery (SPLS) for the treatment of benign ovarian tumors. Methods Eighty patients with benign ovarian tumors who underwent laparoscopic surgery at Peking University First Hospital between Sep- tember 2013 and June 2014 recruited in this study, among them 25 were transumbilical single--incision laparoseopic surgeries (SILS), 25 were single--port laparoscopie surgeries (SPLS) and 30 with conventional multi--port laparo- seopic surgeries (MPLS). Data of these patients were analyzed retrospectively. Results In the three groups, all procedures were performed successfully. There were no differences between SILS, SPLS and MPLS groups in the median operation time (51 min, 56 rain and 45 min, P〉0.05), the median blood loss (10 ml, 10 ml and 15 ml, P〉0. 05), and the absolute decrease of hemoglobin from preoperative to postoperative day 3 measurements (7 g/L, 8 g/L and 6 g/L, P〉0. 05). Conclusion SILS and SPLS are feasible and safe approach for the treatment of benign ovarian tumors.
出处
《中国妇产科临床杂志》
CSCD
北大核心
2015年第3期221-224,共4页
Chinese Journal of Clinical Obstetrics and Gynecology
关键词
单孔腹腔镜
单切口腹腔镜
卵巢肿物
single - incision laparoscopic surgery (SILS)
single - port laparoscopic surgery (SPLS)
ovar-ian tumor